Skip to Main Content
Skip Nav Destination

Issues

Comments

Clin Sci (Lond) (2001) 100 (4): 357–358.
Clin Sci (Lond) (2001) 100 (4): 441–442.

Glaxo/MRS Papers

Clin Sci (Lond) (2001) 100 (4): 359–362.

Original Articles

Clin Sci (Lond) (2001) 100 (4): 363–369.
Clin Sci (Lond) (2001) 100 (4): 371–378.
Clin Sci (Lond) (2001) 100 (4): 379–386.
Clin Sci (Lond) (2001) 100 (4): 387–393.
Clin Sci (Lond) (2001) 100 (4): 395–400.
Clin Sci (Lond) (2001) 100 (4): 401–404.
Clin Sci (Lond) (2001) 100 (4): 405–410.
Clin Sci (Lond) (2001) 100 (4): 411–417.
Clin Sci (Lond) (2001) 100 (4): 423–432.
Clin Sci (Lond) (2001) 100 (4): 433–440.
Clin Sci (Lond) (2001) 100 (4): 443–449.
Clin Sci (Lond) (2001) 100 (4): 451–457.
Clin Sci (Lond) (2001) 100 (4): 459–465.

Letters

Clin Sci (Lond) (2001) 100 (4): 419–420.
Clin Sci (Lond) (2001) 100 (4): 421–422.
Close Modal

or Create an Account

Close Modal
Close Modal